Monitoring Requirements Long. term monitoring of symptoms, GH and IGF1 levels should be undertaken as clinically indicated (for patients being treated for acromegaly). Ultrasonic examination of the abdomen particularly the gall bladder should be undertaken before initiation of treatment and at intervals of 6 β 12 months by specialist. Baseline measurements of LFT and blood glucose.
Appears in 3 contracts
Sources: Shared Care Agreement, Shared Care Agreement, Shared Care Agreement